Mandate

Vinge advises Capio in connection with acquisition of Scanloc

September 01, 2016

Scanloc conducts operations relating to specialist care within eye disorders at clinics situated in Gothenburg and Kungsbacka. The company’s customers primarily consist of the Västra Götaland and Halland County Councils. Scanloc has 35 employees and will be part of Capio Medocular. Closing is scheduled for 30 September and is conditional upon the customary closing conditions from the salient public authorities.

Vinge’s team consisted of responsible partner Anders Strid together with, among others, Frida Bäckergren (project manager), Frida Mattsson (employment), Victor Ericsson (tax) and Gabriella Fossum (public procurement).

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026